38 Stocks Moving In Friday's Mid-Day Session

Gainers

  • Greenland Acquisition Corporation GLAC shares jumped 47.7% to $10.31. Greenland Acquisition reported adjournment of special meeting of shareholders to approve proposed business combination with Zhongchai Holding (Hong Kong) Limited.
  • Attis Industries, Inc. ATIS shares climbed 47.3% to $1.9584 after climbing 37.11% on Thursday.
  • Dermira, Inc. DERM surged 33% to $7.57 after the company presented data from Phase 2b study of lebrikizumab in patients with atopic dermatitis at he 39th Annual Fall Clinical Dermatology Conference in Las Vegas.
  • Ideal Power Inc. IPWR shares gained 11.6% to $2.59 after the company sold its Power Conversion Systems business and Power Packet Switching Architecture technology to CE+T Energy Solutions, Inc.
  • Ruhnn Holding Limited RUHN climbed 10.2% to $4.95.
  • Fluidigm Corporation FLDM shares rose 9.5% to $4.72 after UBS upgraded the company's stock from Neutral to Buy.
  • Sienna Biopharmaceuticals, Inc. SNNA gained 8.1% to $0.1730 as a potential rebound after the stock fell roughly 43% since October 7.
  • Ring Energy, Inc. REI fell 8% to $1.72 after surging 13.33% on Thursday.
  • Borr Drilling Limited BORR shares rose 7.7% to $6.45.
  • Quotient Limited QTNT climbed 7.7% to $8.54.
  • Contango Oil & Gas Company MCF shares climbed 7.7% to $2.3359. Contango named John Goff as new Chairman of the board.
  • Datasea Inc. DTSS shares gained 7.5% to $2.2564.
  • Provention Bio, Inc.PRVB rose 7.1% to $6.45.
  • Ballard Power Systems Inc. BLDP rose 6.6% to $5.63.
  • Kansas City Southern KSU gained 5.2% to $142.50 after the company reported better-than-expected Q3 EPS and sales results.
  • RedHill Biopharma Ltd. RDHL rose 5.2% to $6.49 after the company reported a $36 million strategic investment by Cosmo Pharmaceuticals and U.S. rights to approved Travelers' diarrhea drug Aemcolo.
  • E*TRADE Financial Corp ETFC climbed 4% to $40.53 after the company reported better-than-expected Q3 EPS and sales results.


Check out these big penny stock gainers and losers

Losers

  • Gildan Activewear Inc. GIL shares dipped 20.9% to $28.00 after the company lowered its FY19 earnings guidance. Stifel Nicolaus downgraded the stock from Buy to Hold and lowered the price target from $44 to $30 per share.
  • Navios Maritime Acquisition Corporation NNA shares fell 20.7% to $8.28 after the company reported 1.88 million share offering of common stock at $8 per share.
  • Synthesis Energy Systems, Inc. SES fell 18.7% to $7.48 after rising 26.9% on Thursday.
  • Sensient Technologies Corporation SXT shares fell 11.9% to $58.60 after reporting downbeat Q3 results.
  • Mirati Therapeutics, Inc. MRTX dipped 11.9% to $76.72.
  • Hepion Pharmaceuticals, Inc. HEPA fell 11.7% to $3.1599 after rising 43.20% on Thursday.
  • HyreCar Inc. HYRE dipped 10.8% to $2.14.
  • McDermott International, Inc. MDR dropped 10.3% to $2.225.
  • Exponent, Inc. EXPO tumbled 9.3% to $64.25 following downbeat Q3 sales.
  • Slack Technologies, Inc. WORK dropped 9.3% to $21.78.
  • Can-Fite BioPharma Ltd. CANF shares declined 8.4% to $2.29.
  • L Brands, Inc. LB fell 8.1% to $16.64 after Credit Suisse downgraded the company's stock from Neutral to Underperform and lowered the price target from $22 to $14.
  • Jumia Technologies AG JMIA dropped 7.4% to $7.39 as a potential sell-off after the stock rallied roughly 33% since Tuesday.
  • Signet Jewelers Limited SIG shares declined 7.3% to $14.68.
  • Stage Stores, Inc. SSI shares fell 6.5% to $2.0301.
  • Atlassian Corporation PLC TEAM dropped 6.4% to $114.76 after the company issued FY20 EPS guidance below analyst estimates.
  • The Gap, Inc. GPS fell 6% to $16.51 after Credit Suisse downgraded the company's stock from Neutral to Underperform and lowered the price target from $20 to $14.
  • Coca-Cola FEMSA, S.A.B. de C.V. KOF shares fell 5.4% to $57.93.
  • Pzena Investment Management, Inc PZN shares fell 4.5% to $8.14 after reporting Q3 results.
  • Macy's, Inc. M fell 4% to $15.15 after Credit Suisse downgraded the company's stock from Neutral to Underperform and lowered the price target from $19 to $12.
  • Johnson & Johnson JNJ dropped 4% to $130.81 after the company recalled 1 lot of baby powder due to trace levels of asbestos.
Posted In: Consumer DiscretionaryDepartment StoresMid-Day MoversTop GainersNewsMovers & ShakersIntraday UpdateMarketsMoversTrading IdeasGeneral